Lymphokine-activated killer cell

Results 191 to 200 of about 42,543 (244)

Some of the next articles are maybe not open access.

Effect of ouabain on lymphokine-activated killer cells

International Journal of Immunopharmacology, 1994
A large amount of evidence points towards the potential role of lymphokine activated killer (LAK) cells as tools in the treatment of chronically stressed conditions, such as cancer. The modulation of this activity by biologically active endogenous compounds of the HPA (hypothalamic-pituitary-adrenal) axis, however, is not completely understood. Ouabain,
B, Olej +5 more
openaire +2 more sources

Technical aspects of lymphokine‐activated killer cell production

Journal of Clinical Apheresis, 1988
AbstractAdoptive immunotherapy is a novel approach to treating patients with cancer, utilizing as therapy a patient's own peripheral blood lymphocytes that have been activated by incubation with interleukin‐2 (IL‐2). These cells develop the ability to mediate tumor regression in vivo and are referred to as lymphokine‐activated killer (LAK) cells.
C S, Carter +6 more
openaire +2 more sources

Lymphokine-activated killer cell activity

Immunology Today, 1988
D L, Thiele, P E, Lipsky
openaire +2 more sources

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines.